New York-based Pfizer and Germany’s BioNTech are seen as frontrunners in the race to develop a coronavirus vaccine, alongside Moderna Inc. and AstraZeneca Plc. Bourla said Pfizer and its partner have a 60% chance of knowing the efficacy of its still experimental vaccine by the end of October.
from Hindustan Times - world https://ift.tt/2RnIqHl
via IFTTT
from Hindustan Times - world https://ift.tt/2RnIqHl
via IFTTT
إرسال تعليق